Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Sigyn Therapeutics Inc (OP:SIGY)

0.0221 -0.0069 (-23.79%)
Streaming Delayed Price Updated: 1:37 PM EDT, Sep 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sigyn Therapeutics Inc

< Previous 1 2 3 4 Next >
News headline image
Sigyn Therapeutics Announces Cardiovascular Disease Study
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Death
Sigyn Therapeutics Announces Cardiovascular Disease Study
Via TheNewswire.com
Topics Death
News headline image
RETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
Via ACCESS Newswire
News headline image
Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
Via ACCESS Newswire
News headline image
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Death
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
SAN DIEGO, CA - March 12, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. 
Via TheNewswire.com
Topics Death
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
The Company Invites Investors, Industry Executives, and Analysts to Attend Its Real-time, Interactive Presentation 
Via TheNewswire.com
News headline image
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
SAN DIEGO, CA - March 5, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce. 
Via TheNewswire.com
News headline image
Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst
The Exclusive Event Kicks-Off Tomorrow February 26th at 4pm Eastern 
Via TheNewswire.com
News headline image
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Sigyn Therapeutics to Present at Tomorrow’s Small Cap Growth Virtual Investor Conference
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Small Cap Growth Virtual Investor Conference Agenda Announced for February 6th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Sigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of Directors
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Sigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of Directors
SAN DIEGO, CA - January 29, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a developer of blood purification technologies to treat life-threatening conditions,... 
Via TheNewswire.com
News headline image
OTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand Viewing
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Announces Q1 2024 Financial Results
Via Investor Brand Network
Topics Death
News headline image
Sigyn Therapeutics Reports First Quarter 2024 Financial Results
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Sigyn Therapeutics Reports First Quarter 2024 Financial Results
SAN DIEGO, CA - (NewMediaWire) - May 15, 2024 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced financial results for... 
Via TheNewswire.com
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces Publication of Article on Emerging Candidate – Sigyn Therapy(TM)
Via Investor Brand Network
Topics Death
News headline image
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
Via Investor Brand Network
Topics Death
Sigyn Therapeutics Inc. (SIGY) CEO Discusses Company’s Blood Purification Therapies to Address Cancer and Other Life-Threatening Conditions at the Emerging Growth Conference
Via Investor Brand Network
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Making Drugs Perform Better
Via Investor Brand Network
Topics Death
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Developing Innovative Technologies to Address Critical Healthcare Challenges
Via Investor Brand Network
Topics Death
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Filling Gap in Therapeutic Antibody Treatment Space
Via Investor Brand Network
Topics Death
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces CEO Presentation at Upcoming Emerging Growth Conference
Via Investor Brand Network
Topics Death
News headline image
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.